Vedat’s product portfolio includes plastic closures, PET bottles and other plastic containers and the majority of its customers are in the South American pharmaceutical industry. Gerresheimer CEO Uwe
The study was designed to evaluate the overall survival in unresectable stage III or stage IV melanoma patients who have not received prior therapy. The study compared ipilimumab
The study results revealed that none of the AP doses showed statistically significant improvements over placebo in the analysis of the primary endpoint. Analyses of key secondary endpoints
ARI-3037MO is a structural analog of niacin to treat mixed lipid disorders and hypercholesterolemia in 93 million Americans. Successful completion of preclinical pharmacology and toxicology studies by Arisaph
Hi-Tech is a pharmaceutical company that develops, manufactures and markets generic and branded prescription and OTC products for the general healthcare industry, Nystatin oral suspension is indicated for
Phykitt has spent 17 years researching, testing, patenting and developing Aquaprin, PharmStar’s FDA-approved over-the-counter (OTC) liquid pain reliever. Phykitt has developed a granulation and coating technology in 1970s,
The approval was based on the clinical trial program submitted to date for a new MS drug, and included data from clinical studies showing efficacy in reducing relapses,
The partnership will combine Sage Bionetworks’ expertise in computer models of disease genetics with AstraZeneca’s knowledge and expertise of oncology including access to data on AstraZeneca’s compounds. The
The research effort will seek to determine optimal spatial separation between vaccination sites on the body to avoid immune interference between multiple vaccines. The final testing will involve
The Mimopath technology is based on Lactococcus lactis, a safe bacterium commonly used in the food industry. Mucosis has developed a technique to formulate the L lactis bacteria
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.